Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy.

Huang, Wenfeng; Mao, Yan; Zhan, Yongzi; Huang, Jianfeng; Wang, Xiangping; Luo, Penghui; Li, L I; Mo, Dunchang; Liu, Qiong; Xu, Huimin; Huang, Changjie

Huang, Wenfeng; Mao, Yan; Zhan, Yongzi; Huang, Jianfeng; Wang, Xiangping; Luo, Penghui; Li, L I; Mo, Dunchang; Liu, Qiong; Xu, Huimin; Huang, Changjie.

Afiliação

Huang W; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Mao Y; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Zhan Y; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Huang J; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Wang X; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Luo P; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Li LI; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Mo D; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Liu Q; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Xu H; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.
Huang C; Tumor Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530031, P.R. China.